The share price puts this company in stock-split territory, but it may need to go even higher before management considers one ...
Along with Q1FY27 results, directors will also decide on a proposal to split each Rs 10 share into 10 Re 1 shares.
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative therapies for neurological and neurodegenerative ...
Next Technology Holding Inc. ('NXTT” or the 'Company”) (NASDAQ: NXTT), a technology firm committed to delivering AI-enabled software development services and strategic Bitcoin acquisition, announced ...
The decline in Ajanta Pharma's stock on Wednesday occurs despite robust financial growth observed in both its annual and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results